Research Institutes

Acrc2
A*STAR Computational Resource Centre (A*CRC)
The A*STAR Computational Resource Centre (A*CRC) is a user facility which provides supercomputing resources for the A*STAR research community.

The Centre offers:

  • Compute resource on multiple operating platforms to support a full spectrum of users
  • A comprehensive range of third-party software for a diverse span of applications
  • A friendly and informative web portal
  • Regular roadshows for outreach and feedback sessions
  • Highly-trained HPC support staff for administration and optimization of compute resource
  • Network storage technologies
Go to A*CRC
Matrix_web
Bioinformatics Institute (BII)

BII was established in July 2001 to train manpower and build capabilities in bioinformatics. BII's research focus centres around knowledge discovery from biological data, exploiting high-end computing in biomedicine, advancing molecular imaging of biological processes, modelling of drug design and delivery, computational proteomics and systems biology.

Go to BII
Centros_web2
Bioprocessing Technology Institute (BTI)

The mission of the Bioprocessing Technology Institute (BTI) is to develop manpower capabilities and establish cutting-edge technologies relevant to the bioprocess community. Spearheading bioprocess R&D, the BTI has core expertise in expression engineering, animal cell technology, stem cells, microbial fermentation, product characterisation, downstream processing, purification and stability, with supporting proteomics and microarray platform technologies. BTI, with its R&D and its cGMP manufacturing capabilities, bridges the gaps between discovery, process development and commercialisation.

Go to BTI
Centre for Molecular Medicine (CMM)
Go to CMM
Dsi
Data Storage Institute (DSI)
Spearheading world-class research and development in next generation data storage technologies, the Data Storage Institute (DSI) is positioned to lead and support the growth of the data storage industry in Singapore. With core competencies in magnetic, optical and network storage technologies, DSI is equipped with state-of-the-art facilities for advanced materials and network storage R&D as well as system design and prototyping.

Research undertaken by DSI include:

  • Magnetic head materials and design
  • Microsystems and nanosystems for data storage
  • Signal processing for data storage and communications
  • Tribology and tribochemistry, failure analysis
  • Nano spin-electronics
  • Optical storage technologies
  • Laser nanoprocessing
  • Network storage technologies
Go to DSI
Genome_web
Genome Institute of Singapore (GIS)

Established in June 2000 as the Singapore Genomics Program, the renamed Genome Institute of Singapore (GIS) is a national flagship initiative with a global vision that seeks to use genomic sciences to improve public health and prosperity.
As a centre for genomic discovery, GIS pursues the integration of technology, genetics, and biology towards the goal of individualised medicine. The scientific focus will be to investigate post-sequence genomics; to understand the genetic architecture of pan-Asian populations with emphasis on cancer biology, pharmacogenomics, stem cell biology and infectious diseases. The genomics infrastructure at GIS will be utilized to train new scientific talent, to function as a bridge for academic and industrial research and explore scientific questions of high impact.
Dr Edison Liu, former Director of the National Cancer Institute's Division of Clinical Sciences in the U.S.A., heads the GIS as the Executive Director.

Go to GIS
Iir
Institute for Infocomm Research (I2R)

I2R performs R&D in information, communications and media (ICM) technologies to develop holistic solutions across the ICM value chain. Our research capabilities are in information technology and science, wireless and optical communications, and interactive digital media.

The following are our research departments and programs:

Departments:

  • Communication Systems
  • Computer Graphics and Interface
  • Computer Vision and Image Understanding
  • Cryptography and Security
  • Data Mining
  • Human Language Technology
  • Modulation and Coding
  • Network Protocols
  • RF and Optical
  • Signal Processing

Programmes:

  • Assistive ICT Systems for Monitoring and Rehabilitation for the Elderly
  • High Speed Maritime Mesh Networks
  • Next Generation Content for IPTV
  • Personal 3D Entertainment Systems
  • Power-aware Wireless Sensor Network for Tracking and Monitoring
  • Towards Gigabit Personal Connectivity
Go to I2R
Nanos_web
Institute of Bioengineering & Nanotechnology (IBN)

Bioengineering and nanotechnology represent two frontiers in engineering. They are both multidisciplinary in nature and highly diverse in scope. The Institute of Bioengineering and Nanotechnology (IBN) was founded in 2002 to conduct research at the cutting-edge of these two fields by focusing on the enormous opportunities that are presented at the interface of these emerging technologies.

Specifically, IBN researchers are directing their efforts towards six research areas that are both scientifically exciting and full of potential towards improving our health and quality of life. These include: nanobiotechnology, delivery of drugs, proteins and genes, tissue engineering, artificial organs and implants, medical devices, and biological and biomedical imaging. IBN's target is to create a critical knowledge base in bioengineering and nanotechnology, and to make a significant impact through the generation of new materials, devices, instruments, systems and processes. We are creating technology platforms that will lead to the development of novel products and the growth of new industries through technology licensing, transfer and spin-off.

By fostering a creative, collaborative and resourceful research environment, IBN seeks to establish a world-class and vibrant research institute that attracts international talents and our best young scientists to conduct research in bioengineering and nanotechnology.

Go to IBN
Ices
Institute of Chemical & Engineering Sciences (ICES)
ICES spearheads R&D in Singapore's fast expanding chemical industry. Its core research areas include Applied Catalysis, Particle and Interface Science and Technology, New Synthesis Techniques and Applications and Enabling Technology (process technology, control and characterization). ICES aims to cultivate research talent and promote collaborations between industrial partners and institutions of higher learning (IHLs). To facilitate R&D interactions with the industry, ICES will be located on Jurong Island, Singapore's premiere petrochemical hub and close to the pharmaceutical manufacturing and formulation companies.

Research undertaken by ICES include:

  • Physical, analytical and organic chemistry
  • Chemical process technology
  • Separation technology
  • Catalysis
  • Environmental sciences
  • Analytical science
  • Pharmaceutics
Go to ICES
Ihpc
Institute of High Performance Computing (IHPC)
IHPC undertakes research in computational science and engineering and provides compute intensive resources and services to industry. Its areas of specialisation include Computational Chemistry, Computational Electro Magnetics and Electronics, Computational Fluid Dynamics, Computational Mechanics and Computational Micro-Electro-Mechanical Systems.

Research undertaken by IHPC include:

  • Continuum methods in modeling and simulation
  • Nanomechanics
  • Solid and fluid mechanics
  • Computational chemistry
  • Atomistics and molecular dynamics modeling
Go to IHPC
Imre
Institute of Materials Research and Engineering (IMRE)
IMRE undertakes research in selected fields of materials science and engineering such as optoelectronics, nanomaterials, chemicals and polymers. It seeks to partner with international organisations and industry in a synergistic, multidisciplinary and collaborative approach to materials research and development. To this end, IMRE develops core competence and interdisciplinary teams in critical technology areas, enabling it to make fundamental new discoveries, develop advanced materials that can lead to new commercial products, and transform various technologies.

Research undertaken by IMRE include:

  • Polymer science and chemistry
  • Nanomaterials
  • Advanced materials characterization
  • Performance materials
  • Nanoparticles
  • Macromolecular chemistry
  • Surface science
Go to IMRE
Neuros-immunos3
Institute of Medical Biology (IMB)

The Institute of Medical Biology (IMB) has a strategic, programme-directed portfolio of research focused on issues at the critical interface between basic science and medicine. The aim is to facilitate the development of translational research by building bridges between clinical and basic science. IMB is currently hosting research programmes concerned with different aspects of human disease.

The current programmes within IMB are the Singapore Onco-Genome project, Regenerative Medicine, Papillomavirology, Epithelial Biology and the Lab of Stem Cell Biology from Singapore Stem Cell Consortium (SSCC). The Institute of Medical Biology will help scientists and clinicians to work closely together to support, inform and refine each other’s strengths and specializations to increase the efficiency of the translation process, and ultimately contribute towards a better quality of life for all.

Go to IMB
Ime
Institute of Microelectronics (IME)
The Institute of Microelectronics (IME) helps to drive the continued growth of Singapore ’s electronics industries through high calibre research and development in semiconductor-based technology and solutions. The Institute has three research areas: (1) Integrated Circuits & Systems (RFIC designs for communications and identification applications, RF device modeling, mixed-signal CMOS designs for sensors and bio-electronics applications); (2) Semiconductor Process Technologies (Si-based nano-electronics, heterogeneous materials integration for RF, opto and bio-electronics applications); (3) Microsystems, Modules & Components (bio MEMS devices and bio microfluidic chips, RF and optoelectronic System in Package, fine pitch wafer level packaging, advanced self assembly processes for packaging).

Recent R&D efforts include:

  • 3-10 GHz CMOS pulse-based UWB chip
  • 90 nm RF device modeling
  • Nanoscale CMOS incorporating new materials and structures with emphasis on RF performance
  • Wafer Transfer Technology for multi-functional integration
  • Si based bio-electronic devices / sensors and Si / SiGe based optoelectronics
  • DNA /RNA extraction and amplification chips
  • Fluidic self assembly processes
  • Off chip nano interconnects
  • RF front end module and CWDM / burst mode transceivers integration using System in Package approach 
Go to IME
Proteos_web
Institute of Molecular and Cell Biology (IMCB)

The Institute of Molecular and Cell Biology (IMCB) was established in 1987 to help develop and support biomedical R&D capabilities in Singapore. Currently the institute has 34 independent research groups with more than 400 staff members.

Today, IMCB has established itself as a world-class research institute in biomedical sciences with core strengths in cell cycling, cell signaling, cell death, cell motility and protein trafficking. Its recent achievements include being part of an international consortium which successfully sequenced the entire pufferfish (Fugu) genome - a world first. IMCB was awarded the Nikkei Prize 2000 for Technological Innovation in recognition of its growth into a leading international research centre and its collaboration with industry and research institutes world-wide.

Go to IMCB
SERC Nanofabrication and Characterisation Facility (SNFC)
The SERC Nanofabrication and Characterisation (SNFC) facility aims to make A*STAR’s Science and Engineering Research Council's (SERC) extensive research facilities in Nanofabrication and Characterization technology accessible to the research community. The facility provides easy access to a wide range of research facilities and expertise on a variety of materials. SNFC also offers training courses for new and inexperienced users as well as consultancy and service work on baseline processes and characterizations.

Go to SNFC
Dscn0013
Singapore Institute for Clinical Sciences (SICS)

The Singapore Institute for Clinical Sciences (SICS) will accelerate the translation of basic discoveries into new diagnostics and therapeutics.  SICS will be distinguished by its focus on clinical science and the use of innovative approaches and technologies that enable the efficient and effective study of human health and disease. In so doing, the institute will attract, train and nurture a new type of clinician scientist.  SICS will collaborate with universities, research institutes and clinical programs to achieve the ultimate goal of improving human health as well as Singapore’s economic well-being.

The research focus of SICS will be centered on the human as the model system, and will complement other A*STAR Research Institutes by focusing on the clinical and translational research portion of the spectrum of biomedical research.  SICS will have both intramural research programs and extramural outreach initiatives.
 
Intramural Programs are focused on specific disease areas.  The initial programs at SICS are Genetic Medicine, Hepatic Infectious Diseases andMetabolic Diseases. SICS participates in, or provides oversight to programs external to our institute through our Extramural Programs: Lilly-NUS/SICS Joint Fellowship, Metabolic Interest Group, Supporting the National Medical Research Council in coordinating the STaR Investigatorship Awards and Translational and Clinical Research Flagship Awards
 

Go to SICS
The Chemical Synthesis Laboratory @ Biopolis (CSL)
The Chemical Synthesis Laboratory @ Biopolis extends the current capabilities of the Institute of Chemical & Engineering Sciences (ICES) and complements its chemicals and pharmaceuticals research and development scope from discovery, to development and manufacture of products.
CSL@Biopolis is led by its Programme Director, Professor Kyriacos Costa (K.C.) Nicolaou, Chairman of the Department of Chemistry, the Skaggs Professor of Chemical Biology, and the Darlene Shiley Chair in Chemistry at The Scripps Research Institute and also Professor of Chemistry at the University of California, San Diego.

Go to CSL